Cargando…

Classification of Subgroups with Immune Characteristics Based on DNA Methylation in Luminal Breast Cancer

Luminal breast cancer (BC) accounts for a large proportion of patients in BC, with high heterogeneity. Determining the precise subtype and optimal selection of treatment options for luminal BC is a challenge. In this study, we proposed an MSBR framework that integrate DNA methylation profiles and tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mengyan, Ma, Te, Wang, Cong, Zhao, Jiyun, Xing, Jie, Liu, Honghao, Su, Mu, Zhai, Ruiyang, Liu, Ting, Sun, Baoqing, Zhang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658742/ https://www.ncbi.nlm.nih.gov/pubmed/36361541 http://dx.doi.org/10.3390/ijms232112747

Ejemplares similares

DiseaseMeth version 3.0: a major expansion and update of the human disease methylation database
por: Xing, Jie, et al.
Publicado: (2021)

DNA Methylation-Specific Analysis of G Protein-Coupled Receptor-Related Genes in Pan-Cancer
por: Zhang, Mengyan, et al.
Publicado: (2022)

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
por: Chen, Wenbiao, et al.
Publicado: (2019)

Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016)

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019)

Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer
por: Yin, Xiaoli, et al.
Publicado: (2021)

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
por: Lauss, Martin, et al.
Publicado: (2015)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

Comparative Analysis of Genome Wide DNA Methylation Profiles for the Genic Male Sterile Cabbage Line 01-20S and Its Maintainer Line
por: Han, Fengqing, et al.
Publicado: (2017)

Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions
por: Wang, Seunghyun, et al.
Publicado: (2023)

Developing a weakly supervised deep learning framework for breast cancer diagnosis with HR status based on mammography images
por: Zhang, Mengyan, et al.
Publicado: (2023)

Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes
por: Yu, Ruilin, et al.
Publicado: (2023)

Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation
por: Liu, Yujie, et al.
Publicado: (2022)

Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy
por: Gempt, J., et al.
Publicado: (2022)

Transcriptome Classification Reveals Molecular Subgroups in Patients with Hepatitis B Virus
por: Zhang, Conghui, et al.
Publicado: (2021)

Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
por: Liu, Yuxia, et al.
Publicado: (2022)

Classification of Cerebral Lymphomas and Glioblastomas Featuring Luminance Distribution Analysis
por: Yamasaki, Toshihiko, et al.
Publicado: (2013)

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
por: Lakis, Vanessa, et al.
Publicado: (2021)

Spatiotemporal Characteristics for the Depth from Luminance Contrast
por: Matsubara, Kazuya, et al.
Publicado: (2011)

Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling
por: Cornen, Stéphanie, et al.
Publicado: (2014)

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction
por: Ul Haq, Sami, et al.
Publicado: (2022)

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)

Sarcoma classification by DNA methylation profiling
por: Koelsche, Christian, et al.
Publicado: (2021)

Genome-Wide Analysis of Methylation-Driven Genes and Identification of an Eight-Gene Panel for Prognosis Prediction in Breast Cancer
por: Kuang, Yanshen, et al.
Publicado: (2020)

Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
por: Ma, Xiaoshi, et al.
Publicado: (2020)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
por: Xiao, Bin, et al.
Publicado: (2018)

DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
por: Loh, Marie, et al.
Publicado: (2014)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

MBRS-47. RAPID MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA BASED ON DNA METHYLATION BY NANOPORE SEQUENCING
por: Masliah-Planchon, Julien, et al.
Publicado: (2020)

DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
por: Woltering, Niklas, et al.
Publicado: (2022)

piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer
por: Ding, Xin, et al.
Publicado: (2021)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023)

DNA methylation-based classification of sinonasal tumors
por: Jurmeister, Philipp, et al.
Publicado: (2022)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype
por: Beauchemin, David, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2b8ld30aa5baprbbn2qn6sf3nr